Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apellis Pharmaceuticals
Pharma
With highest quarterly sales since '21, Biogen reverses guidance
Biogen has reversed its 2026 revenue guidance, now expecting a mid-single digit increase versus a previous projection of a mid-single digit decline.
Kevin Dunleavy
Jul 29, 2026 11:05am
Biogen lays out $5.6B to acquire Apellis
Mar 31, 2026 10:32am
Apellis reports 4% sales drop for eye disease med Syfovre
Jan 12, 2026 1:06pm
Apellis snatches broad kidney disease expansion for Empaveli
Jul 28, 2025 8:00pm
With sales turnaround, Astellas projects big growth for Izervay
Jul 10, 2025 4:30pm
Sobi places $300M bet on Empaveli in partnership with Apellis
Jul 1, 2025 11:28am
